| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |